Poster 291 Improved Upper Extremity Spasticity During Continuous Intrathecal Baclofen Trial with High Cervical Catheter Placement: A Case Report

PM&R ◽  
2016 ◽  
Vol 8 (9) ◽  
pp. S255 ◽  
Author(s):  
Melissa Roscher ◽  
Michael C. Munin
PM&R ◽  
2012 ◽  
Vol 4 ◽  
pp. S343-S343 ◽  
Author(s):  
Nancy Henry-Socha ◽  
Nanette Aldahondo ◽  
Peter D. Kim ◽  
Linda E. Krach

2021 ◽  
Vol 12 ◽  
pp. 477
Author(s):  
Thomas Gianaris ◽  
Ryan M. Holland ◽  
Nicolas W. Villelli ◽  
Albert E. Lee

Background: Cerebral palsy with medically refractory spasticity and dystonia is a condition that often benefits from intrathecal baclofen pump therapy to treat these symptoms. In this case report, an intracranial baclofen catheter was placed in the prepontine space to improve withdrawal symptoms in a patient unable to undergo new lumbar catheter placement due to infection. Case Description: A 22-year-old female with past medical history of cerebral palsy presented with baclofen pump failure and was unable to undergo placement of a new lumbar baclofen catheter due to an infection in her lower back precluding safe and efficacious catheter placement. It was decided the patient would benefit from intrathecal baclofen administered in the prepontine space as a means to avoid a lumbar catheter and thus bypass this prior infection site. An endoscopic third ventriculostomy (ETV) was performed with the endoscope and the distal end of the baclofen pump catheter was fed through this ETV into the prepontine space. Placement in the prepontine space was confirmed by a follow-up head computed tomography. There was a significant improvement in autonomic symptoms and spasticity. By postoperative day 5, the patient was surgically and medically cleared for discharge. Conclusion: In cases of severe baclofen withdrawal due to dysfunctional pumps, immediate reversal is preferred but may not be feasible due to factors such as infection. This case report has demonstrated that prepontine catheter placement can be effective for the administration of baclofen to reverse withdrawal symptoms in these types of patients.


2020 ◽  
Vol 81 ◽  
pp. 8
Author(s):  
I. Akgün ◽  
E.E. Avcı ◽  
E. Timurtaş ◽  
İ. Demirbüken ◽  
M.G. Polat

2003 ◽  
Vol 84 (3) ◽  
pp. 458-459 ◽  
Author(s):  
Mrugeshkumar K. Shah ◽  
Randie M. Black-Schaffer

2015 ◽  
Vol 8 (2) ◽  
pp. 104
Author(s):  
Yoon-Kyum Shin ◽  
Ae Ryung Kim ◽  
Jin Woo Chang ◽  
Won Seok Chang ◽  
Don Shin Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document